Rezolute, Inc. (RZLT) stock
RZLTNasdaqPharmaceutical PreparationsFiscal year ends June 30
$4.25+0.24 (+5.85%)
Close on Nov 18, 2026Market cap $411.07MP/E –Yield –
Rezolute cash
Cash and short-term investments held at the end of each period.
Rezolute's cash was $90.00M at Sep 30, 2026. For fiscal 2026 it was $107.80M, down 35.8% from the year before. Over ten years it grew 38.8% a year on average. The highest annual figure on record is $167.86M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $107.80M | -35.8% |
| FY2025 | Jun 30, 2025 | $167.86M | +32.3% |
| FY2024 | Jun 30, 2024 | $126.87M | +24.5% |
| FY2023 | Jun 30, 2023 | $101.90M | -32.3% |
| FY2022 | Jun 30, 2022 | $150.41M | +266.4% |
| FY2021 | Jun 30, 2021 | $41.05M | +312.3% |
| FY2020 | Jun 30, 2020 | $9.96M | -73.5% |
| FY2019 | Jun 30, 2019 | $37.60M | +224.9% |
| FY2018 | Jun 30, 2018 | $11.57M | +157.9% |
| FY2017 | Jun 30, 2017 | $4.49M | +10.5% |
| FY2016 | Jun 30, 2016 | $4.06M | -23.0% |
| FY2015 | Jun 30, 2015 | $5.28M | -11.1% |
| FY2014 | Jun 30, 2014 | $5.93M | +918558.5% |
| FY2011 | Dec 31, 2011 | $646 | +35.1% |
| FY2010 | Dec 31, 2010 | $478 | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $90.00M | -40.9% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $107.80M | -35.8% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $120.27M | +38.4% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $132.94M | +37.7% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $152.19M | +40.6% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $167.86M | +32.3% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $86.89M | +8.6% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $96.54M | +4.3% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $108.27M | +9.7% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $126.87M | +24.5% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $80.02M | -22.4% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $92.60M | -36.9% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $98.73M | -36.0% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $101.90M | -32.3% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $103.06M | +62.5% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $146.75M | +78.1% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $154.32M | +313.8% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $150.41M | +266.4% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $63.42M | +98.2% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $82.40M | +119.2% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $37.29M | +482.3% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $41.05M | +312.3% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $31.99M | +128.0% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $37.60M | +106.8% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $6.40M | -71.0% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $9.96M | -73.5% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $14.03M | +21.3% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $18.18M | +23174.7% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $22.10M | +2446.3% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $37.60M | +836.3% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $11.57M | +157.9% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $78.12K | -98.2% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $868.07K | -75.7% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $4.02M | +19.3% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $4.49M | +10.5% |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $4.44M | +154.1% |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $3.57M | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $3.37M | – |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | $4.06M | – |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | $1.75M | – |
See a number that looks wrong?